MAGNETIC ISOLATION AND MOLECULAR ANALYSIS OF SINGLE CIRCULATING AND DISSEMINATED TUMOR CELLS ON CHIP

Similar documents
Liquid biopsy, a new tool for cancer experts

CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS

Circulating Tumor Cells (CTC) Technologies

Latest developments in Nanodiagnostics

The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer

Alere Technologies GmbH

Prospective Clinical Study of Circulating Tumor Cells For Colorectal Cancer Screening

Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions

Accelerate Your Research with Conversant Bio

Survey Results Q1. How would you best describe your organization?

BBB_company Brief_2018

Disruptive innovation in molecular diagnostics. Hilde Windels CEO Biocartis 25 March 2017

Non-Invasive Array Based Screening for Cancer. Dr. Amit Kumar President and CEO CombiMatrix Corporation

Update on Exact Sciences Molecular CRC Screening Test. November 16 th, 2011

Exosome DNA Extraction Kits

30 years of progress in cancer research

Jules Bordet Institute, Brussels, Belgium Université Libre de Bruxelles Breast International Group (BIG aisbl), Chair ESMO President

Well-known victims of pancreatic cancer

Joachim Eberle Head of R&D, Roche Centralized Diagnostics

GLOBAL NEUROSTIMULATION MARKET

Diagnosis of cancer in the UK, and how it might change in future

TESTIA For INNOVATIVE Solutions

A Novel CTC-Detecting Technique Using TelomeScan and Its Clinical Applications

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Decision Support in Radiation Therapy. Summary. Clinical Decision Support 8/2/2012. Overview of Clinical Decision Support

High Sensitivity Immunomagnetic CTC Isolation as Compared to Alternative Isolation Methods

Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal.

Brochure More information from

Background Information

Market surveillance of medical devices

The use of diagnostic FFPE material in cancer epidemiology research

What EU research policy can do for conditions such as chronic pain?

Challenges for use of CTCs as a Diagnostic. Farideh Z. Bischoff, Ph.D. Interim CSO Sr. Director, Translational Clinical Development Biocept, Inc.

By Sam Toppa BME 281 URI, Fall 2016

Oncology Drug Development Using Molecular Pathology

Genomic Health. Kim Popovits, Chairman, CEO and President

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Bio Compatible Microsystem Packaging of VCSELaser for Implantable Devices

MTC FoF Projects: - AMAZE - ENCOMPASS - OPENHYBRID. Dr. David Brackett Technology Manager Additive Manufacturing AMEF2016,

Novel Diagnostics and Biomarker Opportunities

Early dissemination in prostate cancer

Rapid Point-of-Care Tests for STIs: needs, progress, challenges

UK X-FEL National Laboratory Perspective

Optical cochlear implant project

Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018

SU2C TOP SCIENCE ACCOMPLISHMENTS

Infrastructure for Rapid Assessment of Reliability

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts

Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research

DELIVERABLE REPORT. Grant Agreement number:

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics

INTRODUCTION PREVIOUSLY FUNDED PROJECTS

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

National Academies Next Generation SAMPLE Researchers TITLE Initiative HERE

Noninvasive Glucose Monitors to 2022

CyBio Felix Your Automated Application Starts Here

Corporate Presentation Fourth Quarter 2017

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD

Molecular Diagnostic Solutions for Urologic Cancer

Lynch Syndrome and COLARIS Testing

Personalised Healthcare. will it deliver? Bob Holland Head of Personalised Healthcare & Biomarkers Innovative Medicines AstraZeneca R&D

Potential Opportunities for Collaboration with Pancreatic U01s

Data Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist

AdnaNews. News from the meeting on Advances in Circulating Tumor Cells (ACTC), Reythymnon, Crete, Greece October 8-11, 2014.

Digital Microscopy and Diagnosis on Cellphones

Top Performance in Action. Never confuse movement with action Ernest Hemingway

Microfluidic chip-based diagnostics of cervical cancer

Flow Cytometry Core Facility

Innovations in Lung Cancer Treatment and Research CPAT Seminar June 11, 2014 Scott Santarella, President Bonnie J. Addario Lung Cancer Foundation

Future of Diabetes Research in Europe JDRF Perspective

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595

Catalyzing the Next Generation of Cancer Technologies

Validation of QClamp as Next Generation Liquid Biopsy Technique for Colorectal Cancer He James Zhu M.D. Ph.D

Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast

7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics

BORDET DEPARTMENT RADIATION ONCOLOGY

MARCH 2017 RESEARCH REPORT

Product Overview CELL-FREE DNA BCT CELL-FREE RNA BCT CELL-FREE DNA URINE PRESERVE CYTO-CHEX BCT STRECK CELL PRESERVATIVE

Managing & Aligning Lists of Chemicals of High Concern

The Avatar System TM Yields Biologically Relevant Results

MammaPrint Improving treatment decisions in breast cancer Support and Involvement of EU

Youngnam Cho. National Cancer Center Biomarker Branch

Extracellular Vesicle RNA isolation Kits

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Circulating tumor cells/dna/etc for Radiation Oncologists

Challenges and Opportunities for In Vivo Imaging in Oncology

Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research

IRESSA (Gefitinib) The Journey. Anne De Bock Portfolio Leader, Oncology/Infection European Regulatory Affairs AstraZeneca

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Artificial Intelligence AI for Smarter Healthcare

GENReports: Market & Tech Analysis

GE Healthcare 9900 Innovation Drive Wauwatosa, WI U.S.A.

Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,

1.5. Research Areas Treatment Selection

Monique J. Roobol. Active Surveillance: update on Initiatives

Integrated platform for liquid biopsy-based personalized cancer medicine

Transcription:

MAGNETIC ISOLATION AND MOLECULAR ANALYSIS OF SINGLE CIRCULATING AND DISSEMINATED TUMOR CELLS ON CHIP CRISTINA DE JONCHEERE LIESBET LAGAE, TIM STAKENBORG, CHENGXUN LIU MIRACLE (FP7 257743)

OVERVIEW Miracle aim Importance Challenge Miracle overview Market considerations 2

MIRACLE OVERVIEW Cell isolation with sieve Buffer reservoirs DNA detection Multiplex amplification AIM: A smart miniaturized system for the isolation, counting and molecular characterization of occult tumor cells directly from clinical samples. 3

IMPORTANCE IS CLEAR 13 Million cases of cancer worldwide 1 8 Million cancer related deaths 1 ~50% of cancer patients present with distant or local metastasis 2 Tumors shed approximately 1 million circulating tumor cells per gram of tumor tissue 2 1 AACR 2008 2 M. Campion, J. Voss, and K. Halling, 2011, Comunique 4

CIRCULATING TUMOR CELLS FOR CANCER DIAGNOSIS AND PROGNOSIS CTC in Breast Cancer Prediction of Recurrence (Giatromanolaki et al., 2004) Breast cancer tumor cells in blood has diagnostic and prognostic value BUT: Detection of rare tumor cells in circulation (few in 5 ml of blood) on routine basis is not straightforward 5

WHY USE CTCS? Biotech Industry Novel cancer markers Improved Cancer therapies Less toxic Better Prognosis Reduced mortality Less side effects Clinical evaluation Therapy response monitoring Automated Single Cell Capture & Molecular Analysis On chip For CTC identification User interface Data mining Patient Records Create awareness Promote acceptance Cancer society Clinicians Minimally invasive diagnosis Acurate Therapy Decision Reduced healthcare cost Patients User interface 6

THE CHALLENGE What defines a CTC? Here? 1 Tumor cell 10 5-10 7 peripheral blood mononuclear cells 7

CURRENT APPROACHES FOR CTC DETECTION Nature Reviews Cancer 8, 329-340 (May 2008) 8

CURRENT APPROACHES Circulating tumor cell separation system Immunomagnetic separation of Epcam positive cells using functionalized magnetic nanoparticles Microscopic evaluation of morphology Veridex, a J&J Problem: Only EpCAM company High throughput cell sorter (FACS) Single laser, single detector based sorting Moflo Beckman&Coulter Problem: Sensitivity 100,000 analysis events per second 9

MIRACLE OVERVIEW Key Challenges Using Clinical samples Assay robustness, sensitivity, specificity Flexibility towards downstream processing Use in hospital setting Key objective: Complete integrated platform Direct processing of clinical samples (blood & bone marrow) Single cell sensitivity (macro to micro interface) Multi-type assays (cell assay, RT- PCR and multiplex DNA amplification, DNA detection array) Hetero-integration (combining silicon & polymer technology) Continuous clinical evaluation / design / integration 10

MIRACLE OVERVIEW Immunomagnetic purification Cell isolation with sieve Cell sorting, counting & lysis Buffer reservoirs RT-PCR & DNA multiplex amplification DNA detection Multiplex amplification Hybridization Detection & read-out 11

MIRACLE OVERVIEW Probe immobilizatio n DNA hybridization HRP labeling and detection 12

MIRACLE OVERVIEW Clinical validation Microfluidic s Integrated circuits Molecular biology Nanoparticles 13

ADDRESSING A MEDICAL NEED Mammography Biopsy Surgery Relapse Pain Xray, CT Nothing is analyzed, no test exists!!! radiotherapy chemotherap y Death Therapy monitoring Companion diagnostics Time

SCIENTIFIC IMPACT (MIRACLE) Recent invited publication : Recent invited lectures : May 2010 (Dublin, Ireland) : Single Cell Analysis Congress Sept 2010 (Buenos-Aires, Argentina) : IEEE Engineering in Medicine and Biology Society Sept 2010 (Espoo, Finland) : Microfluidics in Bioanalytical Research and Diagnostics International Scientific Conference February 2011 (Leiden, the Netherlands) : Circulating Tumor Cell Isolation and Diagnostics... LET S KEEP IT THAT WAY 15

THE WORLD IS WATCHING 9/1/2010 EETimes Europe European project MIRACLE to deliver cancer diagnosis lab-on-chip system 9/1/2010 Leuven Inc. European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/7/2010 EETimes Asia Team research to develop lab-on-chip system vs cancer underway 9/2/2010 News Medical MIRACLE project to develop lab-on-chip system for diagnosing cancer 9/1/2010 Azonano imec Launches European Seventh Framework Project MIRACLE 9/6/2010 Elektronik & Data Lab-on-chip skal hjælpe cancerdiagnose 9/3/2010 Bionity.com en European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/3/2010 European Hospital Cheap and fast cancer diagnosis 9/6/2010 Bionity.com de "Lab-on-Chip" zur schnellen Krebsdiagnose: EU-Projekt MIRACLE wird von IMEC koordiniert 9/13/2010 Elektronik Informationen Lab-on-Chip zur schnellen Krebsdiagnose 9/2/2010 CORDIS Nachrichten MIRACLE-Projekt bringt Krebsbehandlung voran 9/2/2010 Elektronik Praxis Schnelle Krebsdiagnose mit "Lab-on-Chip" 9/2/2010 Tech Whack Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/8/2010 EETimes India Lab-on-chip system project to detect cancer cells takes off 9/3/2010 PC's Semiconductor Blog European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 CORDIS News MIRACLE project to advance cancer care 9/6/2010 EuroAlert.net MIRACLE's advanced LOC system, a step further towards better diagnosis of cancer 9/7/2010 Medical Device Network IMEC to Develop Lab-on-Chip Cancer Device 9/2/2010 Medi Lexicon European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 MTB Europe MIRACLE project launched to develop lab-on-chip for cancer diagnosis 9/2/2010 Medical News Today European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 Medical News Today Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/1/2010 Alpha Galileo European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Today's Healthy News Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis 9/3/2010 New Electronics Lab on chip research aims to accelerate detection of cancer 9/3/2010 Drug Discovery World Research To Develop Lab-on-chip System 9/1/2010 Electronic Specifier European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Semiconductor Packaging NewsLab-on-chip project aims to diagnose cancer faster 9/1/2010 Electro IQ (Small Times) Lab-on-chip project aims to diagnose cancer faster 9/1/2010 NanotechWire European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/1/2010 Nanowerk European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Med Tech Insider European Collaborative Research to Develop Lab-on-Chip System for Cancer Diagnosis 9/1/2010 PR ZOOM European Collaborative Research to Develop Lab-on-Chip System for Cheap and Fast Cancer Diagnosis 9/2/2010 Healthcare Technology Online imec European Collaborative Research To Develop Lab-On-Chip System For Cheap And Fast Cancer Diagnosis 9/2/2010 EETimes News & Analyses IMEC launches cancer lab-on-chip project 9/2/2010 Nanotechnology Now Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/2/2010 Genome Web Daily News European Collaboration Launches Effort to Develop Lab-on-Chip for Cancer Dx 9/2/2010 EDA Café Imec European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis 9/8/2010 Semiconductor Packaging NewsImec to develop lab-on-chip system for fast cancer diagnosis 9/1/2010 Newswire Today European Collaborative Research to Develop Lab-on-Chip System for Cheap and Fast Cancer Diagnosis 9/1/2010 HPC Wire Imec's European Collaborative Research to Develop Lab-on-Chip System for Cancer Diagnosis 9/2/2010 Opto IQ (Laser Focus World) European researchers team to develop lab-on-a-chip for cheaper cancer diagnosis 16

MARKET? Lead products Number of cases Number tests of Cost per test Market size USA World CTC prostate 370 000 1 480 000 $300 $444M $11B CTC breast 126 370 505 480 $300 $151M $3.6B CTC colon 74 940 299 760 $300 $90M $2.6B CTC pancreas 37 170 111 510 $300 $33M $792M Urine 870 000 1 740 000 $50 $82M $2B Preclinical drug development 100 000 100 000 $300 $30M $90M Clinical drug development 33 600 134 400 $300 $40M $80M Total 1 612 080 4 371 150 - $870M $20B * Data from Dr. R.J. Cote, 42 nd annual oak ridge conference 2010 17

HOW TO CAPITALIZE ON THIS MARKET? Selling Components Vs. Selling System Regulatory Requirements and Clinical Validation How to cater to all levels of the value chain, or which to prioritize? 18

ACKNOWLEDGEMENTS 19